期刊文献+

清胞饮对高危型人乳头瘤病毒治疗效果的临床研究 被引量:3

Clinical research on effect of Qing Pinocytosis in the treatment of infection patients with high-risk human papilloma virus
下载PDF
导出
摘要 目的探讨清胞饮对官颈内瘤样病变术后高危型人乳头瘤病毒(HPV)治疗效果的临床研究。方法选择2011年9月~2013年9月湖北省十堰市妇幼保健院因宫颈内瘤样病变行Leep术的400例患者.将其分为治疗组和对照组,各200例,治疗组应用清胞饮进行治疗,对照组应用复方黄柏液进行治疗,治疗1、2、4、6个月后对比两组高危型HPV消除率、HPV持续阳性治愈率及转阴率。结果治疗组术后1、2、4、6个月高危型HPV消除率分别为89.00%(178/200)、96.10%(192/200)、97.50%(195/200)、98.60%(198/200);对照组为56.16%(113/200)、64.5%(129/200)、70.25%(144/200)、79.4%(158/200),差异有统计学意义(P〈0.05)。两组高危型HPV消除效果组内比较,差异均有统计学意义(对照组:χ2=13.009,P〈0.05;治疗组:χ2=25.303,P〈0.01)。治疗组治愈率为98.50%,对照组为79.00%,差异有统计学意义(χ2=10.221,P〈0.05)。治疗组转阴率为75.65%,明显高于对照组(21.00%),差异有高度统计学意义(χ2=11.326,P〈0.01);且两组总有效率比较,差异有高度统计学意义(96.50%比64.00%,χ2=14.005,P〈0.01)。结论应用清胞饮对术后高危型HPV持续感染治疗效果显著,可为高危型HPV的治疗提供可靠依据,值得深入研究。 Objective To discuss the clinical research of Qing Pinocytosis in the treatment of infection patients with cervical high-risk human papilloma virus (HPV). Methods 400 cases of women due to cervical within tumor sample le- sions line LeeP surgery from September 2011 to September 2013 in Maternal and Child Health Hospital of Shiyan City in Hubei Province were divided into treatment group and control group, each group had 200 cases, treatment group was applied Qing Pinocytosis for treatment, control group was given Compound Cortex Phellodendri Liquid. The high risk HPV elimination rate, HPV sustained positive rate and negative conversion rate after operation for 1, 2, 4, 6 months be- tween the two groups were compared. Results High-risk HPV eliminating rate of the treatment group after operation for 1, 2, 4, 6 months were 89.00% (178/200), 96.10% (192/200), 97.50% (195/200), 98.60% (198/200); which of the con- trol group were 56.16% (113/200), 64.5% (129/200), 70.25% (144/200), 79.4% (158/200), the differences were statisti- cally significant (P 〈 0.05). Differences of high-risk type HPV elimination effect in the two groups were statistically signif icant (control group: χ2=-13.009, P 〈 0.05; treatment group:χ2=-25.303, P 〈 0.01). The cure rate in treatment group was 98.50%, which of control group was 79.00%, the difference between the two groups was statistically significant (χ2=10.221, P 〈 0.05). The negative conversion rate of the treatment group was 75.65%, which was obviously higher than that of control group (21.00%), the difference was statistically significant (χ2=11.326, P 〈 0.01); and the difference of total effective rate be- tween the two groups was statistically significant (96.50% vs 64.00%, χ2=14.005, P 〈 0.01). Conclusion Application of Qing Pinocytosis on the postoperative high-risk type HPV infection is remarkable, which can provide reliable basis for the treatment of high-risk human papilloma virus, which deserves more in-depth study.
出处 《中国医药导报》 CAS 2014年第13期88-91,共4页 China Medical Herald
基金 湖北省十堰市科学技术研究与开发项目计划(编号083S)
关键词 清胞饮 宫颈瘤样病变 人乳头瘤病毒 临床研究 Qing Pinocytosis Cervical tumor-like lesion Human papilloma virus Clinical research
  • 相关文献

参考文献21

二级参考文献174

共引文献305

同被引文献46

  • 1路俊仙,吕凌,张才波.忍冬4个药用部位中11种化学成分的含量测定[J].中药材,2019,42(5):1085-1089. 被引量:11
  • 2姜建芳,王思平,何新军.中药多糖抗肿瘤作用研究进展[J].中国现代应用药学,2008,25(z1):616-618. 被引量:15
  • 3付金荣.试论湿瘀并存是妇科疾病的病理转归[J].上海中医药杂志,2005,39(12):39-40. 被引量:14
  • 4张颖,郎景和.人乳头状瘤病毒疫苗在子宫颈病变预防与治疗中的应用[J].中华妇产科杂志,2006,41(3):214-216. 被引量:12
  • 5Cai HB,Ding XH,Chen CC_Prevalence of single and multiple human papillomavirus types in cervical cancer and precur-sor lesions in Hube, China[J].Oncology, 2009,76 (3) : 157- 161.
  • 6Papaconstantinou HT, Lee AJ,Simmang CL,et a/.Screen- ing methods for high-grade dysplasia in patients with anal condyloma[J].J Surg Res, 2005,127 ( 1 ) : 8-13.
  • 7Cuzick J, Clavel C, Petry KU,et d.Overview of the European and North American studies on HPV testing in primary cer- vical cancer screening[J].Int J Cancer,2006,119(5) : 1095- 1101.
  • 8Harper DM, Franco EL, Wheeler C,et a/.Efficacy of a bi- valent L1 virus-like particle vaccine in prevention of in- fection with human papillomavirus types 16 and 18 in young women:a randomised controlled trial [J].Lancet, 2004,364(9447) : 1757-1765.
  • 9IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.Human papillomaviruses[J].IARC Monographs on the Evaluation of Carcinogenic Risks to Humans/World Health Organization,International Agency for Research on Cancer,2007,90(1):636.
  • 10沈亮,张辉.子宫颈癌疫苗的研究进展[J].国际妇产科学杂志,2009,36(2):113-116. 被引量:8

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部